Amylin (human) CAS NO.122384-88-7

Amylin (human), also called Islet Amyloid Polypeptide, IAPP, KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTY amide is the amyloidogenic peptide hormone isolated from the amyloid-rich pancreases of diabetic patients. hIAPP forms fibrillar peptide deposits in the pancreatic islets of Langerhans, which may be related to death of the insulin-producing islet β-cells in type 2 diabetes mellitus. Amylin (human) inhibits glucagon secretion, delays gastric emptying, and acts as a satiety agent.

We are thrilled to present our range of pharmaceutical peptide raw materials (both of GMP and non-GMP), designed to empower the development of innovative and effective treatments. Our commitment to excellence in peptide synthesis and manufacturing is evident through our state-of-the-art facilities and years of scientific expertise.

We adhere to Good Manufacturing Practices (GMP), ensuring that our peptides meet the highest quality standards and are suitable for use as active pharmaceutical ingredients (APIs). Our facilities are equipped to handle the complex procedures required for peptide manufacturing, including Solid-Phase Peptide Synthesis (SPPS) and Liquid-Phase Peptide Synthesis (LPPS).

With over 10 years of combined peptide manufacturing experience, we utilize both SPPS and LPPS technologies for production, from gram-scale to kilogram-scale peptide capacity available. Our partnerships span across the globe, ensuring access to cutting-edge technology and expertise.

We look forward to the opportunity to be your trusted partner in the peptide therapeutics market. If you are considering using peptide APIs, please do not hesitate to contact us.